Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' AMBINDER RF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 75 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Berdeja, JG; Jones, RJ; Zahurak, ML; Piantadosi, S; Abrams, RA; Borowitz, MJ; Vogelsang, GB; Noga, SJ; Ambinder, RF; Flinn, IW
      Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Ambinder, RF
      Epstein-Barr virus associated lymphoproliferations in the AIDS setting

      EUROPEAN JOURNAL OF CANCER
    3. Akpek, G; Ambinder, RF; Piantadosi, S; Abrams, RA; Brodsky, RA; Vogelsang, GB; Zahurak, ML; Fuller, D; Miller, CB; Noga, SJ; Fuchs, E; Flinn, IW; O'Donnell, P; Seifter, EJ; Mann, RB; Jones, RJ
      Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    4. Moore, SM; Cannon, JS; Tanhehco, YC; Hamzeh, FM; Ambinder, RF
      Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    5. Murray, PG; Swinnen, LJ; Flavell, JR; Ragni, MV; Baumforth, KRN; Toomey, SM; Filipovich, AH; Lowe, D; Schnell, CS; Johl, J; Gulley, M; Young, LS; Ambinder, RF
      Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas

      HUMAN PATHOLOGY
    6. Chen, HL; Lee, JM; Zong, YS; Borowitz, M; Ng, MH; Ambinder, RF; Hayward, SD
      Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

      JOURNAL OF VIROLOGY
    7. Ciufo, DM; Cannon, JS; Poole, LJ; Wu, FY; Murray, P; Ambinder, RF; Hayward, GS
      Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: Formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures

      JOURNAL OF VIROLOGY
    8. Murray, PG; Flavell, JR; Baumforth, KRN; Toomey, SM; Lowe, D; Crocker, J; Ambinder, RF; Young, LS
      Expression of the tumour necrosis factor receptor-associated factors 1 and2 in Hodgkin's disease

      JOURNAL OF PATHOLOGY
    9. Clarke, CA; Glaser, SL; Dorfman, RF; Mann, R; DiGiuseppe, JA; Prehn, AW; Ambinder, RF
      Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

      CANCER
    10. Ambinder, RF; Sparano, JA
      Primary central nervous system lymphoma

      HIV & HTLV-I ASSOCIATED MALIGNANCIES
    11. Flinn, IW; O'Donnell, PV; Goodrich, A; Vogelsang, G; Abrams, R; Noga, S; Marcellus, D; Borowitz, M; Jones, R; Ambinder, RF
      Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Ambinder, RF
      New controversies and new directions

      CURRENT OPINION IN ONCOLOGY
    13. Flinn, IW; Goodman, SN; Post, L; Jamison, J; Miller, CB; Gore, S; Diehl, L; Willis, C; Ambinder, RF; Byrd, JC
      A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL

      ANNALS OF ONCOLOGY
    14. Cannon, JS; Ciufo, D; Hawkins, AL; Griffin, CA; Borowitz, MJ; Hayward, GS; Ambinder, RF
      A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant

      JOURNAL OF VIROLOGY
    15. Yang, J; Tao, Q; Flinn, IW; Murray, PG; Post, LE; Ma, H; Piantadosi, S; Caligiuri, MA; Ambinder, RF
      Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response

      BLOOD
    16. Flinn, IW; Byrd, JC; Morrison, C; Jamison, J; Diehl, LF; Murphy, T; Piantadosi, S; Seifter, E; Ambinder, RF; Vogelsang, G; Grever, MR
      Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies

      BLOOD
    17. Yang, J; Lemas, VM; Flinn, IW; Krone, C; Ambinder, RF
      Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens

      BLOOD
    18. Ambinder, RF
      Gammaherpesviruses and "hit-and-run" oncogenesis

      AMERICAN JOURNAL OF PATHOLOGY
    19. Schroeder, JR; Saah, AJ; Ambinder, RF; Martinez-Maza, O; Breen, EC; Variakojis, D; Margolick, JB; Jacobson, LP; Rowe, DT; Hoover, DR
      Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue

      CLINICAL IMMUNOLOGY
    20. Schroeder, JR; Saah, AJ; Hoover, DR; Margolick, JB; Ambinder, RF; Martinez-Maza, O; Breen, EC; Jacobson, LP; Variakojis, D; Rowe, DT; Armenian, HK
      Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    21. Ambinder, RF; Robertson, KD; Tao, Q
      DNA methylation and the Epstein-Barr virus

      SEMINARS IN CANCER BIOLOGY
    22. Tao, Q; Ambinder, RF
      Lack of Kaposi's sarcoma - Associated virus (KSHV) and detection of human herpes virus 6 and 7 by PCR in African Burkitt's lymphoma from HIV-negativepatients

      HUMAN PATHOLOGY
    23. Chen, HL; Lee, JM; Wang, YL; Huang, DP; Ambinder, RF; Hayward, SD
      The Epstein-Barr virus latency BamHI-Q promoter is positively regulated bySTATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    24. Cannon, JS; Hamzeh, F; Moore, S; Nicholas, J; Ambinder, RF
      Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir

      JOURNAL OF VIROLOGY
    25. Chen, HL; Smith, P; Ambinder, RF; Hayward, SD
      Expression of Epstein-Barr virus BamHI-A rightward transcripts in latentlyinfected B cells from peripheral blood

      BLOOD
    26. Tao, Q; Swinnen, LJ; Yang, J; Srivastava, G; Robertson, KD; Ambinder, RF
      Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease - Application of PCR-based analysis

      AMERICAN JOURNAL OF PATHOLOGY
    27. Ambinder, RF; Weiss, LM
      Association of Epstein-Barr virus with Hodgkin's disease

      HODGKIN'S DISEASE
    28. Ambinder, RF; Lemas, MV; Moore, S; Yang, J; Fabian, D; Krone, C
      Epstein-Barr virus and lymphoma

      DIAGNOSTIC AND THERAPEUTIC ADVANCES IN HEMATOLOGIC MALIGNANCIES
    29. Sleckman, BG; Mauch, PM; Ambinder, RF; Mann, R; Pinkus, GS; Kadin, ME; Sherburne, B; Perez-Atayde, A; Thior, I; Mueller, N
      Epstein-Barr virus in Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    30. FINN IW; AMBINDER RF
      AIDS ONCOLOGY

      Current opinion in infectious diseases
    31. O'Donnell, PV; Jones, RJ; Vogelsang, GB; Seber, A; Ambinder, RF; Flinn, I; Miller, C; Marcellus, DC; Griffin, C; Abrams, R; Braine, HG; Grever, M; Hess, AD; Piantadosi, S; Noga, SJ
      CD34(+) stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-hostdisease prophylaxis in high-risk hematologic malignancies

      BONE MARROW TRANSPLANTATION
    32. TAO Q; ROBERTSON KD; MANNS A; HILDESHEIM A; AMBINDER RF
      THE EPSTEIN-BARR-VIRUS MAJOR LATENT PROMOTER QP IS CONSTITUTIVELY ACTIVE, HYPOMETHYLATED, AND METHYLATION SENSITIVE

      Journal of virology
    33. CONSTANDINOU CM; LEE S; CROCKER J; YOUNG LS; AMBINDER RF; MURRAY PG
      ANALYSIS OF MHC CLASS-I AND TAP EXPRESSION AND LMP2 EPITOPE SEQUENCE IN EBV-POSITIVE HODGKINS-DISEASE

      Journal of pathology
    34. GLASER SL; AMBINDER RF; DIGIUSEPPE JA; HORNROSS PL; HSU JL
      ABSENCE OF EPSTEIN-BARR-VIRUS EBER-1 TRANSCRIPTS IN AN EPIDEMIOLOGICALLY DIVERSE GROUP OF BREAST CANCERS

      International journal of cancer
    35. TSAI ST; JIN YT; MANN RB; AMBINDER RF
      EPSTEIN-BARR-VIRUS DETECTION IN NASOPHARYNGEAL TISSUES OF PATIENTS WITH SUSPECTED NASOPHARYNGEAL CARCINOMA

      Cancer
    36. MURRAY PG; CONSTANDINOU CM; CROCKER J; YOUNG LS; AMBINDER RF
      ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I, TAP EXPRESSION,AND LMP2 EPITOPE SEQUENCE IN EPSTEIN-BARR VIRUS-POSITIVE HODGKINS-DISEASE

      Blood
    37. TAO Q; ROBERTSON KD; MANNS A; HILDESHEIM A; AMBINDER RF
      EPSTEIN-BARR-VIRUS (EBV) IN ENDEMIC BURKITTS-LYMPHOMA - MOLECULAR ANALYSIS OF PRIMARY TUMOR-TISSUE

      Blood
    38. GRUFFERMAN S; AMBINDER RF; SHUGART YY; BRECHER ML; GILCHRIST GS
      INCREASED CANCER RISK IN FAMILIES OF CHILDREN WITH HODGKINS-DISEASE

      American journal of epidemiology
    39. SHEAFFER JM; NICHOLAS J; BRAVO N; BROWNING PJ; DIGIUSEPPE JA; HAYWARD GS; AMBINDER RF
      LACK OF EXPRESSION OF THE VIRAL IL-6 HOMOLOG IN KSHV-ASSOCIATED TUMORS

      Journal of acquired immune deficiency syndromes and human retrovirology
    40. MOORE SM; AMBINDER RF
      PHARMACOLOGICAL INDUCTION OF EPSTEIN-BARR-VIRUS LYTIC CYCLE - STRATEGIES FOR TUMOR-THERAPY

      Journal of acquired immune deficiency syndromes and human retrovirology
    41. DAVIS JM; LEMAS MV; ORENTAS R; EBY LL; FABIAN D; FLINN I; NOGA SJ; AMBINDER RF
      EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS

      Journal of acquired immune deficiency syndromes and human retrovirology
    42. EIGENMANN PA; AMBINDER RF; LEDERMAN HM
      CHRONIC SINUSITIS WITH ACQUIRED IMMUNOGLOBULIN-A (IGA) DEFICIENCY AFTER BONE-MARROW TRANSPLANTATION

      Otolaryngology and head and neck surgery
    43. ABRAMS RA; LIU PJC; AMBINDER RF; HAULK TL; KORMAN LT; HERMAN MG; JONES RJ
      HODGKIN AND NON-HODGKIN-LYMPHOMA - LOCAL-REGIONAL RADIATION-THERAPY AFTER BONE-MARROW TRANSPLANTATION

      Radiology
    44. ROBERTSON KD; AMBINDER RF
      MAPPING PROMOTER REGIONS THAT ARE HYPERSENSITIVE TO METHYLATION-MEDIATED INHIBITION OF TRANSCRIPTION - APPLICATION OF THE METHYLATION CASSETTE ASSAY TO THE EPSTEIN-BARR-VIRUS MAJOR LATENCY PROMOTER

      Journal of virology
    45. GLASER SL; LIN RJ; STEWART SL; AMBINDER RF; JARRETT RF; BROUSSET P; PALLESEN G; GULLEY ML; KHAN G; OGRADY J; HUMMEL M; PRECIADO MV; KNECHT H; CHAN JKC; CLAVIEZ A
      EPSTEIN-BARR VIRUS-ASSOCIATED HODGKINS-DISEASE - EPIDEMIOLOGIC CHARACTERISTICS IN INTERNATIONAL DATA

      International journal of cancer
    46. ROBERTSON KD; AMBINDER RF
      METHYLATION OF THE EPSTEIN-BARR-VIRUS GENOME IN NORMAL LYMPHOCYTES

      Blood
    47. ORENTAS RJ; NILSEN TW; GETTS RC; ROSKOPF SR; AMBINDER RF
      EPSTEIN-BARR-VIRUS LOAD DETERMINATION BY CELLULAR DILUTION AND MOLECULAR-DETECTION OF EBER-1 SEQUENCES BY RT-PCR AND DNA DENDRIMERS

      Blood
    48. FLINN IW; MORRISON C; MILLER C; AMBINDER RF; JONES RJ
      GOOD PROGNOSIS FOR PATIENTS WHO RECEIVE BMT AFTER HISTORY OF LYMPHOMATOUS MENINGITIS

      Blood
    49. TAO Q; SWINNEN L; AMBINDER RF
      CONSERVATION OF EPSTEIN-BARR-VIRUS (EBV)CTL EPITOPES IN EBV (-ORGAN TRANSPLANT RECIPIENTS() POSTTRANSPLANT LYMPHOMAS IN SOLID)

      Blood
    50. SING AP; AMBINDER RF; HONG DJ; JENSEN M; BATTEN W; PETERSDORF E; GREENBERG PD
      ISOLATION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTES THAT LYSE REED-STERNBERG CELLS - IMPLICATIONS FOR IMMUNE-MEDIATED THERAPY OF EBV(-DISEASE() HODGKINS)

      Blood
    51. AMBINDER RF; ROBERTSON KD; MOORE SM; YANG J
      EPSTEIN-BARR-VIRUS AS A THERAPEUTIC TARGET IN HODGKINS-DISEASE AND NASOPHARYNGEAL CARCINOMA

      Seminars in cancer biology
    52. LIU PC; AMBINDER RF; JONES RJ; ABRAMS RA
      RADIATION-THERAPY AFTER BONE-MARROW TRANSPLANTATION FOR RESISTANT LYMPHOMA

      Radiology
    53. ROBERTSON KD; MANNS A; SWINNEN LJ; ZONG JC; GULLEY ML; AMBINDER RF
      CPG METHYLATION OF THE MAJOR EPSTEIN-BARR-VIRUS LATENCY PROMOTER IN BURKITTS-LYMPHOMA AND HODGKINS-DISEASE

      Blood
    54. LIN AY; KINGMA DW; LENNETTE ET; FEARS TR; WHITEHOUSE JM; AMBINDER RF; JAFFE ES; LEVINE PH; TUCKER MA
      EPSTEIN-BARR-VIRUS AND FAMILIAL HODGKINS-DISEASE

      Blood
    55. DAVIS JM; ORENTAS R; EBY LL; FLINN I; LEMAS MV; NOGA SJ; AMBINDER RF
      GENERATION EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS/

      Blood
    56. FLINN IW; BYRD JC; SEIFTER E; MARCELLUS D; LEE N; DIEHL LF; AMBINDER RF; GREVER MR; VOGELSANG G
      FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY

      Blood
    57. MURRAY PG; SWINNEN LJ; CONSTANDINOU CM; PYLE JM; CARR TJ; HARDWICK JM; AMBINDER RF
      BCL-2 BUT NOT ITS EPSTEIN-BARR VIRUS-ENCODED HOMOLOG, BHRF1, IS COMMONLY EXPRESSED IN POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER

      Blood
    58. DIGIUSEPPE JA; WU TC; ZEHNBAUER BA; MCDOWELL PR; BARLETTA JM; AMBINDER RF; MANN RB
      EPSTEIN-BARR-VIRUS AND PROGRESSION OF NON-HODGKINS-LYMPHOMA TO KI-1-POSITIVE, ANAPLASTIC LARGE-CELL PHENOTYPE

      Modern pathology
    59. MURRAY PG; DEACON E; YOUNG LS; BARLETTA JM; MANN RB; AMBINDER RF; ROWLANDS DC; JONES EL; RAMSAY AD; CROCKER J
      LOCALIZATION OF EPSTEIN-BARR-VIRUS IN CASTLEMANS DISEASE BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY

      Hematologic pathology
    60. BEDI A; MILLER CB; HANSON JL; GOODMAN S; AMBINDER RF; CHARACHE P; ARTHUR RR; JONES RJ
      ASSOCIATION OF BK VIRUS WITH FAILURE OF PROPHYLAXIS AGAINST HEMORRHAGIC CYSTITIS FOLLOWING BONE-MARROW TRANSPLANTATION

      Journal of clinical oncology
    61. ROBERTSON KD; HAYWARD SD; LING PD; SAMID D; AMBINDER RF
      TRANSCRIPTIONAL ACTIVATION OF THE EPSTEIN-BARR-VIRUS LATENCY C PROMOTER AFTER 5-AZACYTIDINE TREATMENT - EVIDENCE THAT DEMETHYLATION AT A SINGLE CPG SITE IS CRUCIAL

      Molecular and cellular biology
    62. SIEBERT JD; AMBINDER RF; NAPOLI VM; QUINTANILLAMARTINEZ L; BANKS PM; GULLEY ML
      HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED HODGKINS-DISEASE CONTAINS LATENT, NOT REPLICATIVE, EPSTEIN-BARR-VIRUS

      Human pathology
    63. TRIANTAFYLLOS JT; JONES RJ; AMBINDER RF; ABRAMS RA
      SINGLE-SITE LYMPHOMA RECURRENCE FOLLOWING BONE-MARROW TRANSPLANT - LONG-TERM SURVIVAL WITH RADIATION-THERAPY

      Blood
    64. FLINN I; ORENTAS R; NOGA SJ; MARCELLUS D; VOGELSAND GB; JONES RJ; AMBINDER RF
      LOW-RISK OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PATIENTS RECEIVING ELUTRIATED ALLOGENEIC MARROW TRANSPLANTS MAY REFLECT DEPLETION OF EBV INFECTED LYMPHOCYTES FROM THE GRAFT

      Blood
    65. ROBERTSON KD; MANNS A; SWINNEN LJ; HAYWARD SD; AMBINDER RF
      ESCAPE FROM EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELL IMMUNESURVEILLANCE IN NEOPLASTIC AND NONNEOPLASTIC B-CELLS IS FACILITATED BY METHYLATION OF A CRUCIAL SITE IN THE MAJOR VIRAL LATENCY PROMOTER

      Blood
    66. LIU PJ; AMBINDER RF; JONES RJ; ABRAMS RA
      LOCAL-REGIONAL RADIOTHERAPY FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) FOR PATIENTS WITH CHEMOTHERAPY RESISTANT LYMPHOMA

      Blood
    67. MACMAHON EME; AMBINDER RF
      EBER IN-SITU HYBRIDIZATION - SENSITIVE DETECTION OF LATENT EPSTEIN-BARR-VIRUS IN INDIVIDUAL CELLS

      Reviews in medical virology
    68. WEIL MK; HESS A; SARCINELLI FP; CARTER D; AMBINDER RF
      ADOPTIVE CELLULAR IMMUNOTHERAPY PROTECTS AGAINST EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE

      AIDS research and human retroviruses
    69. KINGMA DW; MEDEIROS LJ; BARLETTA J; RAFFELD M; MANN RB; AMBINDER RF; JAFFE ES
      EPSTEIN-BARR-VIRUS IS INFREQUENTLY IDENTIFIED IN NON-HODGKINS-LYMPHOMAS ASSOCIATED WITH HODGKINS-DISEASE

      The American journal of surgical pathology
    70. AMBINDER RF; MANN RB
      EPSTEIN-BARR-ENCODED RNA IN-SITU HYBRIDIZATION - DIAGNOSTIC APPLICATIONS

      Human pathology
    71. AMBINDER RF; MANN RB
      DETECTION AND CHARACTERIZATION OF EPSTEIN-BARR-VIRUS IN CLINICAL SPECIMENS

      The American journal of pathology
    72. BARLETTA JM; KINGMA DW; LING Y; CHARACHE P; MANN RB; AMBINDER RF
      RAPID INSITU HYBRIDIZATION FOR THE DIAGNOSIS OF LATENT EPSTEIN-BARR-VIRUS INFECTION

      Molecular and cellular probes
    73. RYON JJ; HAYWARD SD; MACMAHON EME; MANN RB; LING Y; CHARACHE P; PHELAN JA; MILLER G; AMBINDER RF
      IN-SITU DETECTION OF LYTIC EPSTEIN-BARR-VIRUS INFECTION - EXPRESSION OF THE NOTI EARLY GENE AND VIRAL INTERLEUKIN-10 LATE GENE IN CLINICAL SPECIMENS

      The Journal of infectious diseases
    74. RYON JJ; HAYWARD SD; MANN RB; AMBINDER RF
      DEFECTIVE CONTROL OF EPSTEIN-BARR-VIRUS (EBV) INFECTION IN AIDS - INSITU DETECTION OF LATENT (EBER-1) AND LYTIC (NOT1 AND VIL-10) TRANSCRIPTS IN LYMPHOID AND EPITHELIAL TISSUES

      The Journal of immunology
    75. AMBINDER RF; RAGNI MV; BARLETTA J; BASS D; DUERSTEIN S; MANN RB
      EPSTEIN-BARR-VIRUS (EBV) ASSOCIATION OF LYMPHOMA IN PATIENTS WITH HEMOPHILIA AND AIDS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:27:16